31 related articles for article (PubMed ID: 1977490)
1. Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis.
Narayan N; Rigby S; Carlucci F
Clin Rheumatol; 2017 Feb; 36(2):477-479. PubMed ID: 27778097
[TBL] [Abstract][Full Text] [Related]
2. Neutropaenia in early rheumatoid arthritis: frequency, predicting factors, natural history and outcome.
Fragoulis GE; Paterson C; Gilmour A; Derakhshan MH; McInnes IB; Porter D; Siebert S
RMD Open; 2018; 4(2):e000739. PubMed ID: 30402267
[TBL] [Abstract][Full Text] [Related]
3. Neutropenia in the Elderly: A Rheumatology Perspective.
Yeoh SA; Fox C; Hull R
Drugs Aging; 2016 Aug; 33(8):585-601. PubMed ID: 27402172
[TBL] [Abstract][Full Text] [Related]
4. Fatal neutropenic enterocolitis associated with sulphasalazine therapy for rheumatoid arthritis.
Chakravarty K; Scott DG; McCann BG
Br J Rheumatol; 1992 May; 31(5):351-3. PubMed ID: 1349846
[TBL] [Abstract][Full Text] [Related]
5. Fatal agranulocytosis in sulfasalazine treated rheumatoid arthritis.
Guillemin F; Aussedat R; Guerci A; Lederlin P; Trechot P; Pourel J
J Rheumatol; 1989 Aug; 16(8):1166-7. PubMed ID: 2573730
[No Abstract] [Full Text] [Related]
6. Sulphasalazine in rheumatoid arthritis.
Boey ML; Lee E; Feng PH
Singapore Med J; 1988 Jun; 29(3):285-8. PubMed ID: 2903555
[No Abstract] [Full Text] [Related]
7. Sulphasalazine in rheumatoid arthritis.
McConkey B; Amos RS; Durham S; Forster PJ; Hubball S; Walsh L
Br Med J; 1980 Feb; 280(6212):442-4. PubMed ID: 6102877
[TBL] [Abstract][Full Text] [Related]
8. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
Bax DE; Amos RS
Ann Rheum Dis; 1985 Mar; 44(3):194-8. PubMed ID: 2858182
[TBL] [Abstract][Full Text] [Related]
9. Neutropenia in patients with rheumatoid arthritis, treated with sulphasalazine.
Marouf ES; Morris IM
Br J Rheumatol; 1990 Oct; 29(5):407-9. PubMed ID: 1977490
[No Abstract] [Full Text] [Related]
10. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
Mundo A; Pedone V; Lamanna G; Cervini C
Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840
[TBL] [Abstract][Full Text] [Related]
11. Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review.
Pullar T; Capell HA
Drugs; 1986; 32 Suppl 1():54-7. PubMed ID: 2877854
[TBL] [Abstract][Full Text] [Related]
12. The clinical efficacy of sulphasalazine in rheumatic disease.
Taggart AJ
Agents Actions Suppl; 1988; 24():189-96. PubMed ID: 2903619
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
